Anders Elm Pedersen

Anders Elm Pedersen

Guest researcher


  1. 2005
  2. Published

    Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination.

    Pedersen, Anders Elm, Thorn, M., Gad, M., Walter, M. R., Johnsen, H. E., Gaarsdal, E., Nikolajsen, K., Buus, Søren, Claesson, Mogens Helweg & Svane, I. M., 2005, In: Scandinavian Journal of Immunology. 61, 2, p. 147-56 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Treatment of transplanted CT26 tumour with dendritic cell vaccine in combination with blockade of vascular endothelial growth factor receptor 2 and CTLA-4.

    Pedersen, Anders Elm, Buus, Søren & Claesson, Mogens Helweg, 2005, In: Cancer Letters. 235, 2, p. 229-38 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2004
  5. Published

    Changes in protein expression in p53 deleted spontaneous thymic lymphomas.

    Honoré, B., Vorum, H., Pedersen, Anders Elm, Buus, Søren & Claesson, Mogens Helweg, 2004, In: Experimental Cell Research. 295, 1, p. 91-101 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells.

    Gad, M., Pedersen, Anders Elm, Kristensen, N. N. & Claesson, Mogens Helweg, 2004, In: European Journal of Immunology. 34, 3, p. 695-704 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3).

    Pedersen, Anders Elm, Gad, M., Walter, M. R. & Claesson, Mogens Helweg, 2004, In: Immunology Letters. 91, 1, p. 63-9 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

    Svane, I. M., Pedersen, Anders Elm, Johnsen, H. E., Nielsen, D., Kamby, C., Gaarsdal, E., Nikolajsen, K., Buus, Søren & Claesson, Mogens Helweg, 2004, In: Cancer Immunology, Immunotherapy. 53, 7, p. 633-41 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2003
  10. Published

    Dendritic cells in peripheral tolerance and immunity.

    Gad, M., Claesson, Mogens Helweg & Pedersen, Anders Elm, 2003, In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 111, 7-8, p. 766-75 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Tumor-associated antigens identified by mRNA expression profiling as tumor rejection epitopes.

    Andersen, M., Ruhwald, M., Thorn, M., Pedersen, Anders Elm, Mathiassen, S., Buus, S. & Claesson, Mogens Helweg, 2003, In: Journal of Immune Based Therapies and Vaccines. 1, 1, p. 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. 1999
  13. Published

    MHC class I cross-talk with CD2 and CD28 induces specific intracellular signalling and leads to growth retardation and apoptosis via a p56(lck)-dependent mechanism.

    Ruhwald, M., Pedersen, Anders Elm & Claesson, Mogens Helweg, 1999, In: Experimental and Clinical Immunogenetics. 16, 4, p. 199-211 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    MHC-I-induced apoptosis in human B-lymphoma cells is dependent on protein tyrosine and serine/threonine kinases.

    Pedersen, Anders Elm, Bregenholt, S., Johansen, B., Skov, Søren & Claesson, Mogens Helweg, 1999, In: Experimental Cell Research. 251, 1, p. 128-34 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 8473